65. Primary immunodeficiency Clinical trials / Disease details
Clinical trials : 500 / Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02231983 (ClinicalTrials.gov) | September 2014 | 1/9/2014 | Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China | Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China | Severe Combined Immunodeficiency | Genetic: gene sequencing | Shanghai Children's Medical Center | NULL | Not yet recruiting | 2 Months | 2 Years | Both | 50 | N/A | China |